Ingevity Corporation (NYSE:NGVT) Receives $80.00 Average Target Price from Brokerages

Ingevity Corporation (NYSE:NGVT) has received a consensus rating of “Hold” from the five research firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $80.00.

NGVT has been the subject of a number of analyst reports. BMO Capital Markets reissued an “outperform” rating and issued a $83.00 price objective on shares of Ingevity in a research report on Monday, March 2nd. Wall Street Zen cut shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Monday, March 9th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research note on Thursday, January 22nd. Jefferies Financial Group restated a “buy” rating and set a $82.00 price objective on shares of Ingevity in a report on Thursday, February 26th. Finally, Wells Fargo & Company upped their target price on Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th.

Ingevity Stock Performance

NYSE NGVT opened at $70.74 on Monday. The company has a quick ratio of 0.79, a current ratio of 1.33 and a debt-to-equity ratio of 39.10. Ingevity has a fifty-two week low of $28.49 and a fifty-two week high of $77.46. The business has a fifty day moving average of $69.35 and a 200-day moving average of $60.61. The stock has a market cap of $2.50 billion, a price-to-earnings ratio of -15.21 and a beta of 1.31.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.16). Ingevity had a positive return on equity of 126.25% and a negative net margin of 13.51%.The company had revenue of $255.10 million for the quarter, compared to analysts’ expectations of $257.27 million. During the same quarter in the prior year, the business posted $0.95 EPS. The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. As a group, analysts predict that Ingevity will post 4.45 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of NGVT. Principal Financial Group Inc. lifted its holdings in shares of Ingevity by 269.9% during the 4th quarter. Principal Financial Group Inc. now owns 652,237 shares of the company’s stock worth $38,599,000 after acquiring an additional 475,907 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after purchasing an additional 454,579 shares during the period. Simcoe Capital Management LLC grew its holdings in Ingevity by 188.8% in the second quarter. Simcoe Capital Management LLC now owns 624,935 shares of the company’s stock valued at $26,928,000 after purchasing an additional 408,508 shares during the period. Boston Partners increased its position in Ingevity by 141.6% during the fourth quarter. Boston Partners now owns 620,360 shares of the company’s stock worth $36,719,000 after purchasing an additional 363,584 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of Ingevity by 137.7% during the 4th quarter. Goldman Sachs Group Inc. now owns 424,038 shares of the company’s stock valued at $25,095,000 after buying an additional 245,620 shares during the period. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.